title: [Non-urothelial neoplasm in patients with infiltrating bladder carcinoma].
abstract: OBJECTIVE
  To analyze the incidence of non-urothelial neoplasms in patients with infiltrating bladder tumor submitted to radical surgery.
  
  
  METHODS
  A retrospective study was conducted in patients who underwent radical cystoprostatectomy for an infiltrating bladder tumor from 1987-1996. The pathological and follow-up data were analyzed.
  
  
  RESULTS
  Of 120 patients submitted to radical cystoprostatectomy for an infiltrating bladder tumor, 23 (19%) had an associated non-urothelial neoplasm: 14 (61%) were metachronous and 9 (39%) were synchronous. Two patients had two secondary tumors (9%).
  
  
  CONCLUSIONS
  We have found a high incidence of non-urothelial tumor in patients with infiltrating bladder tumor. By order of frequency, these were prostate cancer, gastrointestinal cancer, pulmonary cancer, etc. Studies have ascribed the association of prostate and bladder cancer to the deletion of suppressor genes.
authors.affiliation: Servicio de Urología, Hospital General Universitario de Murcia, España.
authors.forename: P L
authors.initials: PL
authors.lastname: Guzmán Martínez-Valls
authors.forename: R
authors.initials: R
authors.lastname: Ferrero Doria
authors.forename: J P
authors.initials: JP
authors.lastname: Morga Egea
authors.forename: J
authors.initials: J
authors.lastname: Navas Pastor
authors.forename: M
authors.initials: M
authors.lastname: Tomás Ros
authors.forename: J L
authors.initials: JL
authors.lastname: Rico Galiano
authors.forename: A
authors.initials: A
authors.lastname: Sempere Gutiérrez
authors.forename: L O
authors.initials: LO
authors.lastname: Fontana Compiano
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000453:epidemiology*; D012189:Retrospective Studies; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology*
vernacular_title: Neoplasia asociada de estirpe no urotelial en pacientes con carcinoma vesical infiltrante.